Mammographic Density and Risk of Second Breast Cancer after Ductal Carcinoma In situ
暂无分享,去创建一个
L. Habel | C. Quesenberry | A. Capra | Laurel A. Habel | Angela M. Capra | Ninah S. Achacoso | Aradhana Janga | Luana Acton | Balaram Puligandla | Charles P. Quesenberry | B. Puligandla | N. Achacoso | Luana Acton | Aradhana Janga
[1] B. Hulka,et al. Steroid hormones and risk of breast cancer , 1994, Cancer.
[2] D. Schultz,et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. , 2001, International journal of radiation oncology, biology, physics.
[3] Linda Olson,et al. Effects of Estrogen and EstrogenProgestin on Mammographic Parenchymal Density , 1999, Annals of Internal Medicine.
[4] R N Hoover,et al. Mammographic densities and risk of breast cancer , 1991, Cancer.
[5] M. Pike,et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.
[6] D. Trichopoulos,et al. Mammary Gland Mass and Breast Cancer Risk , 1992, Epidemiology.
[7] T. Tuttle,et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] K. Kerlikowske,et al. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. , 2000, Archives of internal medicine.
[9] N. Boyd,et al. Relationship between mammographic and histological risk factors for breast cancer. , 1992, Journal of the National Cancer Institute.
[10] R. J. Brenner. Conjugated Equine Estrogen Influence on Mammographic Density in Postmenopausal Women in a Substudy of the Women's Health Initiative Randomized Trial , 2010 .
[11] N. Boyd,et al. Mammographic densities and breast cancer risk. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[12] Ikuko Kato,et al. A nested case-control study of mammographic patterns, breast volume, and breast cancer (New York City, NY, United States) , 1995, Cancer Causes & Control.
[13] J Costantino,et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17 , 1999, Cancer.
[14] Pathologic findings from the national surgical adjuvant breast project (NSABP) eight‐year update of protocol B‐17 , 2000, Cancer.
[15] Laurence L. George,et al. The Statistical Analysis of Failure Time Data , 2003, Technometrics.
[16] M. Pike,et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. , 1994, Journal of the National Cancer Institute.
[17] V T Farewell,et al. The analysis of failure times in the presence of competing risks. , 1978, Biometrics.
[18] J. Stanford,et al. Risk of recurrence after ductal carcinoma in situ of the breast. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[19] N. Boyd,et al. Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence , 2008, Breast Cancer Research.
[20] A. Oza,et al. Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.
[21] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data , 1980 .
[22] K. Chew,et al. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. , 2009, International journal of radiation oncology, biology, physics.
[23] R N Hoover,et al. Mammographic parenchymal patterns as indicators of breast cancer risk. , 1989, American journal of epidemiology.
[24] J. Costantino,et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] D. Miglioretti,et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography , 2003, Annals of Internal Medicine.
[26] Stephen W Duffy,et al. Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.
[27] L. Kolonel,et al. The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort , 2006, Breast Cancer Research.
[28] C. Byrne,et al. Studying mammographic density: implications for understanding breast cancer. , 1997, Journal of the National Cancer Institute.
[29] D. Miglioretti,et al. Association between Breast Density and Subsequent Breast Cancer Following Treatment for Ductal Carcinoma In situ , 2007, Cancer Epidemiology Biomarkers & Prevention.
[30] A. Miller,et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.
[31] J. Wolfe,et al. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. , 1987, AJR. American journal of roentgenology.
[32] N. Krieger. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.
[33] J. Wolfe,et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.
[34] S. Joslyn. Ductal Carcinoma in Situ: Trends in Geographic, Temporal, and Demographic Patterns of Care and Survival , 2006, The breast journal.
[35] M S Pepe,et al. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.
[36] K. Kerlikowske,et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. , 2002, Journal of the National Cancer Institute.
[37] James Dignam,et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.
[38] N. Gordon,et al. Some evidence refuting the HMO "favorable selection" hypothesis: the case of Kaiser Permanente. , 1991, Advances in health economics and health services research.
[39] R. Hiatt,et al. The frequency of kidney and urinary tract diseases in a defined population. , 1982, Kidney international.
[40] S. Ingles,et al. Serum prolactin levels are positively associated with mammographic density in postmenopausal women , 2007, Breast Cancer Research and Treatment.
[41] Gary J. Whitman,et al. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery , 2010 .
[42] N. Weiss,et al. Risk of contralateral breast cancer among women with carcinoma in situ of the breast. , 1997, Annals of surgery.
[43] E White,et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.
[44] V. McCormack,et al. Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.
[45] M. Szklo,et al. Mammographic parenchymal patterns and breast cancer risk. , 1987, Epidemiologic reviews.
[46] N F Boyd,et al. The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.
[47] James J Dignam,et al. Mammographic density and breast cancer after ductal carcinoma in situ. , 2004, Journal of the National Cancer Institute.
[48] T. Tuttle,et al. Trends in the treatment of ductal carcinoma in situ of the breast. , 2004, Journal of the National Cancer Institute.